$MRAI
Marpai, Inc.

2022 Q4 Form 10-Q Financial Statement

#000095017022023823 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $7.628M $4.938M
YoY Change 29.38% 2.89%
Cost Of Revenue $4.813M $3.625M
YoY Change 13.88% 8.44%
Gross Profit $2.816M $1.313M
YoY Change 68.6% -9.85%
Gross Profit Margin 36.91% 26.58%
Selling, General & Admin $9.424M $3.772M
YoY Change 55.39% -1.23%
% of Gross Profit 334.68% 287.33%
Research & Development $1.024M $781.8K
YoY Change 66.3% 37.43%
% of Gross Profit 36.37% 59.55%
Depreciation & Amortization $1.094M $82.07K
YoY Change 48.19% 40.18%
% of Gross Profit 38.86% 6.25%
Operating Expenses $11.54M $4.553M
YoY Change 55.57% 3.78%
Operating Profit -$8.727M -$5.814M
YoY Change 51.79% 22.78%
Interest Expense -$254.3K $2.908K
YoY Change 494.2% -97.32%
% of Operating Profit
Other Income/Expense, Net $138.9K $56.27K
YoY Change 118.93% 3.0%
Pretax Income -$9.055M -$5.780M
YoY Change 58.07% 20.6%
Income Tax -$521.1K $0.00
% Of Pretax Income
Net Earnings -$8.534M -$5.780M
YoY Change 48.97% 20.6%
Net Earnings / Revenue -111.87% -117.05%
Basic Earnings Per Share -$0.28
Diluted Earnings Per Share -$0.41 -$0.28
COMMON SHARES
Basic Shares Outstanding 20.94M 20.68M
Diluted Shares Outstanding 20.35M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.76M $4.748M
YoY Change -28.25% 298.66%
Cash & Equivalents $13.76M $4.748M
Short-Term Investments
Other Short-Term Assets $10.95M $5.333M
YoY Change 46.18% -37.88%
Inventory
Prepaid Expenses
Receivables $1.438M $191.2K
Other Receivables $30.63K $56.83K
Total Short-Term Assets $26.54M $10.35M
YoY Change -1.68% 1.77%
LONG-TERM ASSETS
Property, Plant & Equipment $1.506M $737.4K
YoY Change 69.24% 2.34%
Goodwill $5.837M $2.383M
YoY Change 144.95% 42.16%
Intangibles $6.323M $4.930M
YoY Change 14.81% -24.2%
Long-Term Investments
YoY Change
Other Assets $21.67K $80.61K
YoY Change -73.12% 54.19%
Total Long-Term Assets $23.41M $15.07M
YoY Change 36.04% -11.97%
TOTAL ASSETS
Total Short-Term Assets $26.54M $10.35M
Total Long-Term Assets $23.41M $15.07M
Total Assets $49.95M $25.41M
YoY Change 13.0% -6.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.458M $692.9K
YoY Change 29.47% -73.86%
Accrued Expenses $5.275M $2.339M
YoY Change 108.9% 20.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.36M $8.650M
YoY Change 55.76% -41.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $20.20M $45.00K
YoY Change 44797.11% 0.0%
Total Long-Term Liabilities $20.20M $45.00K
YoY Change 44797.11% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.36M $8.650M
Total Long-Term Liabilities $20.20M $45.00K
Total Liabilities $43.82M $11.42M
YoY Change 202.32% -49.6%
SHAREHOLDERS EQUITY
Retained Earnings -$47.99M -$39.46M
YoY Change 122.96% 149.79%
Common Stock $2.128K $2.094K
YoY Change 4.83% 87.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $6.134M $13.99M
YoY Change
Total Liabilities & Shareholders Equity $49.95M $25.41M
YoY Change 13.0% -6.85%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$8.534M -$5.780M
YoY Change 48.97% 20.6%
Depreciation, Depletion And Amortization $1.094M $82.07K
YoY Change 48.19% 40.18%
Cash From Operating Activities -$19.90M -$5.217M
YoY Change 277.71% 701.74%
INVESTING ACTIVITIES
Capital Expenditures $85.54K -$260.0K
YoY Change -118.51% -7.05%
Acquisitions
YoY Change
Other Investing Activities $33.39M
YoY Change
Cash From Investing Activities $33.30M -$260.0K
YoY Change -7305.71% -7.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 200.0 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -19.90M -5.217M
Cash From Investing Activities 33.30M -260.0K
Cash From Financing Activities 200.0 0.000
Net Change In Cash 13.40M -5.477M
YoY Change -20.85% -589.15%
FREE CASH FLOW
Cash From Operating Activities -$19.90M -$5.217M
Capital Expenditures $85.54K -$260.0K
Free Cash Flow -$19.99M -$4.957M
YoY Change 315.8% 1236.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001844392
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40904
dei Entity Registrant Name
EntityRegistrantName
MARPAI, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
86-1916231
dei Entity Address Address Line1
EntityAddressAddressLine1
5701 East Hillsborough Ave., Suite 1417
dei Entity Address City Or Town
EntityAddressCityOrTown
Tampa
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33610‑5428
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
303‑3483
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
MRAI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20937901
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4747951
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19183044
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
4966443
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1165248
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6750599
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
191194
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
845790
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
208762
CY2022Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
16332
CY2021Q4 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
5541067
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
870790
CY2021Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
14978
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
366307
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
743126
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
56832
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
91498
CY2022Q3 us-gaap Assets Current
AssetsCurrent
10345059
CY2021Q4 us-gaap Assets Current
AssetsCurrent
26992007
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
737441
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5411009
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1525639
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2043624
CY2022Q3 us-gaap Goodwill
Goodwill
2382917
CY2021Q4 us-gaap Goodwill
Goodwill
2382917
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4929736
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5507693
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80610
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
80610
CY2022Q3 us-gaap Assets
Assets
25412411
CY2021Q4 us-gaap Assets
Assets
44201640
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
692919
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1125906
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2338652
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2022Q3 mrai Accrued Fiduciary Obligations Current
AccruedFiduciaryObligationsCurrent
3898847
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
784493
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3200
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8650198
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
11145388
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
45000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
728436
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1301828
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2001012
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2001012
CY2022Q3 us-gaap Liabilities
Liabilities
11424646
CY2021Q4 us-gaap Liabilities
Liabilities
14493228
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
227791050
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20937901
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20937901
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20299727
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20299727
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
2094
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2030
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
53445687
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51232092
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39460016
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-21525710
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
568817
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2684014
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1118191
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13987765
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
25412411
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44201640
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4938105
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4799251
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16713420
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8330763
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
3625415
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
3343196
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
12323770
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6063679
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2717905
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2229809
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7940014
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5044759
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1053814
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1588981
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4829718
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3032766
CY2022Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1538136
CY2021Q3 us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
770124
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
3862142
us-gaap Information Technology And Data Processing
InformationTechnologyAndDataProcessing
1501354
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
781750
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
842047
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
802240
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2443856
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1223207
CY2022Q3 mrai Facilities Expense
FacilitiesExpense
193494
CY2021Q3 mrai Facilities Expense
FacilitiesExpense
231841
mrai Facilities Expense
FacilitiesExpense
586430
mrai Facilities Expense
FacilitiesExpense
458733
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-60471
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
10752561
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
9535008
us-gaap Costs And Expenses
CostsAndExpenses
34730415
us-gaap Costs And Expenses
CostsAndExpenses
18442689
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5814456
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4735757
us-gaap Operating Income Loss
OperatingIncomeLoss
-18016995
us-gaap Operating Income Loss
OperatingIncomeLoss
-10111926
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
56274
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
54637
CY2022Q3 us-gaap Interest Expense
InterestExpense
2908
CY2021Q3 us-gaap Interest Expense
InterestExpense
108503
us-gaap Interest Expense
InterestExpense
7415
us-gaap Interest Expense
InterestExpense
384564
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18770
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2956
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5461
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-18740
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
95565
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
109063
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5779860
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4792579
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-17934306
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10406167
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-150000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5779860
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4792579
us-gaap Net Income Loss
NetIncomeLoss
-17934306
us-gaap Net Income Loss
NetIncomeLoss
-10256167
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.47
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.90
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.90
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20348655
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20348655
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10261001
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10261001
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20019116
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20019116
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7846348
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7846348
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
19070499
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
689375
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
25
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
7726
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-5779860
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13987765
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
9151173
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
256137
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-4792579
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4614780
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
29708412
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2182696
us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
61
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
30902
us-gaap Net Income Loss
NetIncomeLoss
-17934306
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
13987765
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3496499
mrai Stock Issued During Period Value Exchange With Subsidiary
StockIssuedDuringPeriodValueExchangeWithSubsidiary
-14
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17351935
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
53333
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
397317
mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
1642220
mrai Increase Decrease In Accrued Fiduciary Obligations
IncreaseDecreaseInAccruedFiduciaryObligations
-993041
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-512095
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-74096
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1566439
mrai Increase Decrease In Accounts Payable Related Party
IncreaseDecreaseInAccountsPayableRelatedParty
-15725
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-436385
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
962143
us-gaap Net Income Loss
NetIncomeLoss
-10256167
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4614780
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
us-gaap Profit Loss
ProfitLoss
-17934306
us-gaap Profit Loss
ProfitLoss
-10256167
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2443856
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1223207
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-60471
us-gaap Share Based Compensation
ShareBasedCompensation
2432758
us-gaap Share Based Compensation
ShareBasedCompensation
962143
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30899
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
517985
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
42799
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
26728
us-gaap Paid In Kind Interest
PaidInKindInterest
352171
mrai Convertible Notes Issued In Exchange For Services
ConvertibleNotesIssuedInExchangeForServices
-75000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-150000
mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
-16215
mrai Increase Decrease In Accounts Receivable And Unbilled Receivable
IncreaseDecreaseInAccountsReceivableAndUnbilledReceivable
245481
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-376821
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
380738
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-34665
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-47202
us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
2592
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-432986
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-437
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-240001
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-294458
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
147001
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15339217
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5526568
us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
11384035
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
809856
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1211511
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
70176
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66617
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-880032
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10105907
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
49
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
550000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2000000
CY2022Q3 mrai Working Capital
WorkingCapital
1694861
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
0
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4747951
us-gaap Net Income Loss
NetIncomeLoss
-17934306
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15339217
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
53333
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2603382
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16219249
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
7182721
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25933643
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1817932
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9714394
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000653
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4747951
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1190974
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
4966443
CY2021Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
7809679
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9714394
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9000653
CY2021Q1 mrai Number Of Healthcare Subsidiaries
NumberOfHealthcareSubsidiaries
2
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39460016
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the accompanying condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingencies at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Such estimates include, but are not limited to, valuation of share-based compensation, valuation of the Company’s common stock prior to the IPO, accounting for warrants, allowance for doubtful accounts, useful lives of internally developed software, fair values of net assets acquired, goodwill, intangible assets and property and equipment, whether an arrangement is or contains a lease, the incremental borrowing rate used for operating leases, income tax accruals, the valuation allowance for deferred income taxes, and contingent liabilities.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from those estimates.</span></p>
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
355940
mrai Accounts Receivable Payments Term
AccountsReceivablePaymentsTerm
P30D
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1185518
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
484562
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3979997
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6286562
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
12545844
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-12311864
mrai Business Acquisitions Incremental Amortization Expense Related To Intangible And Tangible Assets Acquired
BusinessAcquisitionsIncrementalAmortizationExpenseRelatedToIntangibleAndTangibleAssetsAcquired
303556
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1222003
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
651898
CY2022Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
568195
CY2021Q3 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
525345
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
575357
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
436699
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
191786
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
218349
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2558649
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
295583
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
737441
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
889935
us-gaap Depreciation
Depreciation
164800
us-gaap Depreciation
Depreciation
134609
CY2022Q3 us-gaap Depreciation
Depreciation
82066
CY2021Q3 us-gaap Depreciation
Depreciation
58545
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
60471
CY2022Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7529900
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
7161571
CY2022Q3 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
2890427
CY2021Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1186727
CY2022Q3 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
4639473
CY2021Q4 mrai Capitalized Computer Software Net Of Accumulated Amortization And In Process
CapitalizedComputerSoftwareNetOfAccumulatedAmortizationAndInProcess
5974844
CY2022Q3 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
771536
CY2021Q4 mrai Capitalized Computer Software In Process
CapitalizedComputerSoftwareInProcess
330010
CY2022Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
5411009
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
6304854
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
1703699
CY2021Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
743038
CY2022Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY2022Q3 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
355940
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
14986742
CY2021Q4 us-gaap Noncurrent Assets
NoncurrentAssets
17129023
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
297000
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3200
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3637
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
720549
CY2021Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
897288
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
929688
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q4 mrai Performance Guarantee Liabilities Current
PerformanceGuaranteeLiabilitiesCurrent
418988
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
332475
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
465723
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2338652
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2525037
CY2021Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
4.555821
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
24547086
CY2021Q4 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
783257
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
22500
CY2022Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
7500
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0144
mrai Maximum Percentage Of Taxable Income Can Be Utilized For Operating Losses
MaximumPercentageOfTaxableIncomeCanBeUtilizedForOperatingLosses
0.80

Files In Submission

Name View Source Status
0000950170-22-023823-index-headers.html Edgar Link pending
0000950170-22-023823-index.html Edgar Link pending
0000950170-22-023823.txt Edgar Link pending
0000950170-22-023823-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrai-20220930.htm Edgar Link pending
mrai-20220930.xsd Edgar Link pending
mrai-ex31_1.htm Edgar Link pending
mrai-ex31_2.htm Edgar Link pending
mrai-ex32_1.htm Edgar Link pending
mrai-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
mrai-20220930_cal.xml Edgar Link unprocessable
mrai-20220930_def.xml Edgar Link unprocessable
mrai-20220930_lab.xml Edgar Link unprocessable
mrai-20220930_pre.xml Edgar Link unprocessable
mrai-20220930_htm.xml Edgar Link completed
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable